Sponsor Pipeline

GÜLDEN ANATACA Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-30 NCT07736079 Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome Not Yet Recruiting
2026-07-29 NCT07734558 Evaluation of Neuregulin-4 (NRG4) Levels in Obese and Non-Obese Patients With Type 2… Not Yet Recruiting
2026-07-29 NCT07734597 Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy? Not Yet Recruiting
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07734558 Evaluation of Neuregulin-4 (NRG4) Levels in Obese and Non-Obese Patients With Type 2… Type 2 Diabetes Mellitus (T2DM) Not Yet Recruiting
NCT07734597 Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy? Polyneuropathies Not Yet Recruiting
NCT07736079 Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome Polycystic Ovary Syndrome (PCOS) Not Yet Recruiting
Disease Areas
Get alerts when GÜLDEN ANATACA's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free